Postprandial increase in plasma concentrations of remnant-like particles: An independent risk factor for restenosis after percutaneous coronary intervention

被引:11
|
作者
Oi, K [1 ]
Shimokawa, H [1 ]
Hirakawa, Y [1 ]
Tashiro, H [1 ]
Nakaike, R [1 ]
Kozai, T [1 ]
Ohzono, K [1 ]
Yamamoto, K [1 ]
Koyanagi, S [1 ]
Okamatsu, S [1 ]
Tajimi, T [1 ]
Kikuchi, Y [1 ]
Takeshita, A [1 ]
机构
[1] Kyushu Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
angioplasty; coronary artery disease; remnant lipoproteins; restenosis;
D O I
10.1097/00005344-200407000-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Postprandial increase in remnant lipoprotein concentrations has been suggested as an important atherogenic factor. However, the influence of these remnants on the development of restenosis after percutaneous coronary intervention (PCI) remains to be examined. The present study was designed to address this point. In 60 consecutive patients with successful PCI, the influences of possible risk factors on the development of restenosis, including remnant-like particles (RLP) cholesterol (RLP-C) and triglyceride (RLP-TG), were examined. While mean concentrations of RLP-C and RLP-TG were normal in fasting state, postprandial change in RLP-C concentrations was a significant and independent risk factor for restenosis after PCI. The calculated cut-off index (COI) for the change was + 64%. When the patients were divided into 2 groups according to this COI, minimal lumen diameter (MLD) and reference coronary diameter were comparable before and immediately after PCI between the high- (COI greater than or equal to 64%) and the low- (COI < 64%) responders. However, follow-up coronary angiography 3 to 6 months after PCI demonstrated that MLD, late loss, and loss index were all worse in the high responders compared with the low responders. These results indicate that postprandial increase in RLP-C concentrations is an independent risk factor for restenosis after successful PCI, even in patients with normal fasting RLP-C levels.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 34 条
  • [1] Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention
    Lupi, Alessandro
    Secco, Gioel Gabrio
    Rognoni, Andrea
    Rossi, Lidia
    Lazzero, Maurizio
    Nardi, Federico
    Rolla, Roberta
    Bellomo, Giorgio
    Bongo, Angelo Sante
    Di Mario, Carlo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (04) : 308 - 317
  • [2] Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients
    Inoue, T
    Uchida, T
    Kamishirado, H
    Takayanagi, K
    Hayashi, T
    Morooka, S
    Saniabadi, AR
    Nakajima, K
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (05) : 298 - 302
  • [3] Association between LDL particle size and postprandial increase of remnant-like particles in Japanese type 2 diabetic patients
    Takayanagi, N
    Onuma, T
    Kato, S
    Nishiyama, K
    Nomiyama, T
    Kawamori, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (03) : 245 - 252
  • [4] Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
    Zholdybayeva, Elena V.
    Talzhanov, Yerkebulan A.
    Aitkulova, Akbota M.
    Tarlykov, Pavel V.
    Kulmambetova, Gulmira N.
    Iskakova, Aisha N.
    Dzholdasbekova, Aliya U.
    Visternichan, Olga A.
    Taizhanova, Dana Zh
    Ramanculov, Yerlan M.
    HUMAN GENOMICS, 2016, 10
  • [5] Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention
    Alessandro Lupi
    Gioel Gabrio Secco
    Andrea Rognoni
    Lidia Rossi
    Maurizio Lazzero
    Federico Nardi
    Roberta Rolla
    Giorgio Bellomo
    Angelo Sante Bongo
    Carlo Di Mario
    Journal of Thrombosis and Thrombolysis, 2012, 33 : 308 - 317
  • [6] Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention
    Monraats, Pascalle S.
    de Vries, Florentine
    de Jong, Laura W.
    Pons, Douwe
    Sewgobind, Varsha D. K. D.
    Zwinderman, Aeilko H.
    De Maat, Moniek P. M.
    't Hart, Leen M.
    Doevendans, Pieter A.
    de Winter, Robbert J.
    Tio, Rene A.
    Waltenberger, Johannes
    Frants, Rune R.
    van der Laarse, Arnoud
    Van der Wall, Ernst E.
    Jukema, J. Wouter
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (10) : 747 - 754
  • [7] Plasma Phospholipids and Sphingolipids Identify Stent Restenosis After Percutaneous Coronary Intervention
    Cui, Song
    Li, Kefeng
    Ang, Lawrence
    Liu, Jinghua
    Cui, Liqian
    Song, Xiantao
    Lv, Shuzheng
    Mahmud, Ehtisham
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (13) : 1307 - 1316
  • [8] Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
    Elena V. Zholdybayeva
    Yerkebulan A. Talzhanov
    Akbota M. Aitkulova
    Pavel V. Tarlykov
    Gulmira N. Kulmambetova
    Aisha N. Iskakova
    Aliya U. Dzholdasbekova
    Olga A. Visternichan
    Dana Zh. Taizhanova
    Yerlan M. Ramanculov
    Human Genomics, 10
  • [9] An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitus
    Diedrichs, H.
    Pfister, R.
    Hagemeister, J.
    Mueller-Ehmsen, J.
    Frank, K. F.
    Hoepp, H. -W.
    Erdmann, E.
    Schneider, C. A.
    DIABETIC MEDICINE, 2008, 25 (02) : 228 - 231
  • [10] Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis
    Miao, Hai-Wei
    Gong, Hui
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (04) : 844 - 850